Stock PLASMATECH BIOPHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Editorial Features Plasmatech Biopharmaceuticals Inc Nasdaq

Equities

US72754H1095

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Plasmatech Biopharmaceuticals Inc
May. 30 Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target MT
May. 16 Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Global markets live: Netflix, Novartis, Tesla, Autodesk, AMC...Global markets live: Netflix, Novartis, Tesla, Autodesk, AMC... July 21, 2021 at 11:55 am EDT
Global markets live: LVMH, Apple, Microsoft, ABB, SoftwareOne...Global markets live: LVMH, Apple, Microsoft, ABB, SoftwareOne... July 20, 2021 at 11:48 am EDT
Global markets live: Salesforce, Intel, Wisekey...Global markets live: Salesforce, Intel, Wisekey... June 30, 2021 at 10:10 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. Stock
  5. News Plasmatech Biopharmaceuticals Inc
  6. MarketScreener Editorial Features